MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 188.18 million in assets under management.

Index Performance

Index performance of price, total return net and total return gross indices is displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
Year-to-Date Performance14.29%16.18%16.68%
1-Year Performance6.40%8.19%8.67%
3-Year Performance21.42%28.06%29.53%
5-Year Performance-2.86%6.27%8.25%
Since Inception (29 Sep 2000)98.34%187.55%134.43%

Index Records

Index highs and lows of price, total return net and total return gross indices are displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
All Time High/Low2,325.90 / 551.16 3,118.07 / 560.95 2,500.60 / 976.33
52-Weeks High/Low1,983.35 / 1,651.54 2,875.49 / 2,355.48 2,344.31 / 1,912.16
Quarter High/Low1,983.35 / 1,727.76 2,875.49 / 2,498.60 2,344.31 / 2,035.35
Month High/Low1,983.35 / 1,876.09 2,875.49 / 2,716.54 2,344.31 / 2,214.09

Index Correlation and Volatility

Index correlation to selected index peers and index volatility are updated daily.

Index Correlation
MSCI ACWI Pharmaceuticals0.8065
DJ US Pharmaceuticals TSM0.8312
Index Volatility
22-day Volatility11.67
250-day Volatility15.33

Component Performance

Displayed are the best and worst index components over a selected period of time. Data is updated daily.

Best 5 Components1-YearYear-to-Date1-Day
ABBVIE INC3.92%-0.61%0.16%
ASTRAZENECA PLC-SPONS ADR28.71%31.01%0.44%
BRISTOL-MYERS SQUIBB CO23.25%24.32%0.52%
GLAXOSMITHKLINE PLC-SPON ADR30.06%27.16%0.30%
JOHNSON & JOHNSON-1.06%12.31%0.71%
ELI LILLY & CO7.88%6.74%0.11%
MERCK & CO. INC.18.57%18.80%-0.13%
NOVARTIS AG-ADR23.14%25.16%0.26%
NOVO-NORDISK A/S-SPONS ADR27.95%25.54%-0.14%
PFIZER INC-9.94%-9.20%-0.68%
SANOFI-ADR13.72%16.11%1.91%
TEVA PHARMACEUTICAL-SP ADR-48.35%-38.00%0.74%
AMERISOURCEBERGEN CORP7.07%18.70%-0.12%
MCKESSON CORP18.79%31.34%0.43%
ZOETIS INC38.47%45.37%0.64%
PERRIGO CO PLC-6.39%41.29%0.22%
MYLAN NV-36.50%-31.35%0.62%
JAZZ PHARMACEUTICALS PLC5.51%19.49%-1.29%
GW PHARMACEUTICALS -ADR-16.35%5.64%0.41%
PATTERSON COMPANIES INC4.06%21.43%-1.82%
CATALENT INC43.87%67.35%-1.71%
BAUSCH HEALTH COS INC27.08%58.80%0.31%
ELANCO ANIMAL HEALTH INC-18.72%-15.03%1.25%
AMARIN CORPORATION PLC -ADR37.66%67.60%-1.81%
TAKEDA PHARM-ADR27.57%23.52%-0.89%
Worst 5 Components1-YearYear-to-Date1-Day
ABBVIE INC3.92%-0.61%0.16%
ASTRAZENECA PLC-SPONS ADR28.71%31.01%0.44%
BRISTOL-MYERS SQUIBB CO23.25%24.32%0.52%
GLAXOSMITHKLINE PLC-SPON ADR30.06%27.16%0.30%
JOHNSON & JOHNSON-1.06%12.31%0.71%
ELI LILLY & CO7.88%6.74%0.11%
MERCK & CO. INC.18.57%18.80%-0.13%
NOVARTIS AG-ADR23.14%25.16%0.26%
NOVO-NORDISK A/S-SPONS ADR27.95%25.54%-0.14%
PFIZER INC-9.94%-9.20%-0.68%
SANOFI-ADR13.72%16.11%1.91%
TEVA PHARMACEUTICAL-SP ADR-48.35%-38.00%0.74%
AMERISOURCEBERGEN CORP7.07%18.70%-0.12%
MCKESSON CORP18.79%31.34%0.43%
ZOETIS INC38.47%45.37%0.64%
PERRIGO CO PLC-6.39%41.29%0.22%
MYLAN NV-36.50%-31.35%0.62%
JAZZ PHARMACEUTICALS PLC5.51%19.49%-1.29%
GW PHARMACEUTICALS -ADR-16.35%5.64%0.41%
PATTERSON COMPANIES INC4.06%21.43%-1.82%
CATALENT INC43.87%67.35%-1.71%
BAUSCH HEALTH COS INC27.08%58.80%0.31%
ELANCO ANIMAL HEALTH INC-18.72%-15.03%1.25%
AMARIN CORPORATION PLC -ADR37.66%67.60%-1.81%
TAKEDA PHARM-ADR27.57%23.52%-0.89%
Up